secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silexion Therapeutics Corp (SLXN)
CIK:        0002022416
Form:       8-K
Filed at:   2026-09-25T20:15:34+00:00
Accession:  0001178913-26-004609
Event type: regulatory
Sentiment:  negative
Materiality: 0.72
Item codes: 3.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Silexion gets Nasdaq bid-price notice after 30 days below $1.00; hearings panel to weigh listing
--------------------------------------------------------------------------------

- Nasdaq Listing Qualifications staff letter dated September 25, 2026 says SLXN ordinary shares closed below the $1.00 minimum bid for 30 consecutive business days, breaching Listing Rule 5550(a)(2).
- Nasdaq's hearings panel will consider the bid price deficiency in deciding whether Silexion may remain listed on the Nasdaq Capital Market.
- Nasdaq says the letter has no immediate effect: ordinary shares keep trading as SLXN and listed warrants keep trading as SLXNW.
- Warrants to buy ordinary shares carry an exercise price of $15,525.00 per share; ordinary shares have $0.135 par value.
- Company says it cannot assure ongoing compliance with the bid price rule or other Nasdaq listing requirements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2022416/000117891326004609/0001178913-26-004609-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2022416/000117891326004609/zk2636161.htm
  HTML page:      https://secwatch.observer/filing/0001178913-26-004609

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer